AngioDynamics Inc
ANGO10.560USD
+0.500+4.97%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
439.02M시가총액
손실P/E TTM
자세한 내용은 AngioDynamics Inc 회사
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
AngioDynamics Inc 정보
종목 코드 ANGO
회사 이름AngioDynamics Inc
상장일May 27, 2004
CEOClemmer (James C)
직원 수675
유형Ordinary Share
회계 연도 종료May 27
주소14 Plaza Drive
도시LATHAM
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호12110
전화15187981215
웹사이트https://www.angiodynamics.com/
종목 코드 ANGO
상장일May 27, 2004
CEOClemmer (James C)
AngioDynamics Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+890.00%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-36233.00%
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Mr. James C. Clemmer
Mr. James C. Clemmer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Independent Director
Independent Director
--
--
Mr. Warren G. Nighan
Mr. Warren G. Nighan
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
--
--
Mr. Chad T. Campbell
Mr. Chad T. Campbell
Senior Vice President, General Manager - Global Oncology and Vascular Access
Senior Vice President, General Manager - Global Oncology and Vascular Access
--
--
Ms. Karen A. Licitra
Ms. Karen A. Licitra
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+890.00%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-36233.00%
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Mr. James C. Clemmer
Mr. James C. Clemmer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
수익 분석
통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
United States
66.46M
87.78%
International
9.26M
12.22%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Wed, Feb 4
마지막 업데이트: Wed, Feb 4
주주
주주 유형
주주
주주
비율
Divisadero Street Capital Management, LP
8.92%
BlackRock Institutional Trust Company, N.A.
7.04%
Systematic Financial Management, L.P.
6.24%
Point72 Asset Management, L.P.
6.21%
The Vanguard Group, Inc.
5.91%
기타
65.68%
주주
주주
비율
Divisadero Street Capital Management, LP
8.92%
BlackRock Institutional Trust Company, N.A.
7.04%
Systematic Financial Management, L.P.
6.24%
Point72 Asset Management, L.P.
6.21%
The Vanguard Group, Inc.
5.91%
기타
65.68%
주주 유형
주주
비율
Investment Advisor
35.12%
Investment Advisor/Hedge Fund
34.15%
Hedge Fund
19.12%
Individual Investor
6.43%
Venture Capital
3.46%
Research Firm
2.32%
Pension Fund
1.68%
Bank and Trust
0.25%
Insurance Company
0.03%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
311
40.19M
106.71%
-10.46K
2025Q3
344
40.20M
109.06%
+1.51M
2025Q2
370
37.97M
110.38%
+1.85M
2025Q1
372
36.50M
106.59%
-6.63M
2024Q4
361
34.34M
98.76%
+1.35M
2024Q3
371
33.44M
109.60%
-216.03K
2024Q2
370
33.66M
118.59%
-3.23M
2024Q1
368
36.03M
115.74%
-10.10M
2023Q4
378
37.01M
114.23%
+355.36K
2023Q3
364
36.64M
109.90%
-219.51K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Divisadero Street Capital Management, LP
3.68M
8.92%
+282.69K
+8.33%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
2.90M
7.04%
-61.07K
-2.06%
Sep 30, 2025
Systematic Financial Management, L.P.
2.57M
6.24%
+60.60K
+2.41%
Sep 30, 2025
Point72 Asset Management, L.P.
2.56M
6.21%
+609.91K
+31.29%
Sep 30, 2025
The Vanguard Group, Inc.
2.36M
5.74%
-125.09K
-5.03%
Sep 30, 2025
Armistice Capital LLC
1.64M
3.97%
+108.19K
+7.08%
Sep 30, 2025
Segall Bryant & Hamill, LLC
1.32M
3.2%
-37.14K
-2.74%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.16M
2.8%
-16.92K
-1.44%
Sep 30, 2025
Clemmer James C
1.13M
2.74%
+10.00K
+0.89%
Oct 09, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
State Street SPDR S&P Health Care Equipment ETF
0.79%
Invesco NASDAQ Future Gen 200 ETF
0.63%
Vanguard US Multifactor ETF
0.15%
iShares Micro-Cap ETF
0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.08%
Invesco Russell 2000 Dynamic Multifactor ETF
0.07%
Fidelity Enhanced Small Cap ETF
0.06%
Avantis US Small Cap Equity ETF
0.06%
Invesco RAFI US 1500 Small-Mid ETF
0.04%
iShares Russell 2000 Value ETF
0.02%
더 보기
State Street SPDR S&P Health Care Equipment ETF
비율0.79%
Invesco NASDAQ Future Gen 200 ETF
비율0.63%
Vanguard US Multifactor ETF
비율0.15%
iShares Micro-Cap ETF
비율0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
비율0.08%
Invesco Russell 2000 Dynamic Multifactor ETF
비율0.07%
Fidelity Enhanced Small Cap ETF
비율0.06%
Avantis US Small Cap Equity ETF
비율0.06%
Invesco RAFI US 1500 Small-Mid ETF
비율0.04%
iShares Russell 2000 Value ETF
비율0.02%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
